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Abstract
Background: Robotic adrenalectomy offers several clinical benefits if compared with laparoscopic adrenalectomy;
however, its superiority is still under debate. The aim of this study was the investigation of differences between the
two techniques, and a comparison when approaching right or left side adrenal lesions was further conducted.
Materials and Methods: All patients undergoing laparoscopic and robotic unilateral adrenalectomy at our
institution from January 2006 to December 2019 were collected and retrospectively analyzed. Statistical anal-
ysis was conducted; differences between the two cohorts were reported.
Results: A total of 160 cases were included (84 patients in laparoscopic adrenalectomy-group [LA-g] 76 cases in
robotic adrenalectomy-group [RA-g]). The groups were homogeneous for demographic data. No intraoperative
complications were reported; mean amount of intraoperative blood loss was comparable. No cases of conversion
to open surgery were required. RA-g presented a longer operative time than LA-g for right adrenalectomy
(P = .05), no differences were noted for left side (P = .187). Overall morbidity was 21% for LA-g and 10.5% for
RA-g (P = .087), with an inferior rate of surgical complications for RA-g (P = .024), and for robotic left adre-
nalectomy than robotic right procedure (P = .03). Length of hospital stay was shorter for RA-g (P = .005).
Conclusions: Robotic adrenalectomy presents similar outcomes as laparoscopic approach with some benefits
for selected cases. Left adrenal lesions seem to receive greater advantages from robotic technique. Large
randomized controlled trials are required to determine the role of robotic adrenal surgery and if the indication
can be standardized based on the laterality of adrenal procedure.
Keywords: adrenalectomy, adrenal gland surgery, robotic adrenalectomy, laparoscopic adrenalectomy, robotic
surgery
Introduction
In recent years, mini-invasive robot-assisted adrenalec-tomy was introduced as an alternative technique to conven-
tional laparoscopic approach to overcome some drawbacks
of laparoscopic surgery.1,2 Authors consider adrenal surgery
a technically demanding procedure requiring meticulous
dissection in a relatively limited space dealing with major
vessels and organs in an adrenal cortical-sparing optic3,4;
thus, many surgeons, thanks to the stereoscopic vision, im-
proved magnification and greater range of motion within a
limited working space, find in the robotic platform a benefi-
cial alternative to conventional laparoscopic approach.4–6
Nevertheless, laparoscopic adrenalectomy (LA) still remains
the gold standard procedure,2 no clear improvements from
the use of the robotic platform have been validated in
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comparative studies and large series evaluating clinical out-
comes after robotic adrenalectomy are currently not avail-
able.4,7 In particular, the debate is still open concerning
specific parameters, such as body mass index (BMI), size
of the lesion and laterality of adrenal gland, and standard
indications of robot application to adrenal surgery are still
lacking.5,7,8 We present in this study the experience in mini-
invasive surgical treatment of adrenal glands at our Insti-
tution, where in past years robotic adrenalectomy has
progressively juxtaposed to laparoscopic technique. Purpose
of our study was to compare outcomes of the two surgical
approaches, mainly investigating specific variables, such as
BMI and tumor size, to rule out if and when robot-assisted
approach can be preferable to conventional laparoscopy. The
second endpoint was to compare outcomes of right- versus
left-sided adrenal lesions for both the techniques. To the
best of our knowledge this is the largest series of adrenal
procedures comparing laparoscopic and robotic approach at




A retrospective observational study of adrenal surgical
procedures performed at our institution between January
2006 and December 2019 was conducted. All consecutive
patients older than 18 years who underwent mini-invasive,
laparoscopic and robotic, adrenal surgery for benign and
malignant lesions were included; open and bilateral adrena-
lectomies represented exclusion criteria. The Da Vinci Si
robotic system (Intuitive Surgical, Inc., Sunnyvale, CA) was
applied. All included patients were operated by one senior
surgeon with an established experience in mini-invasive and
adrenal surgery. Data were inserted into a database utilizing
medical records. The study was conducted in accordance
with the Declaration of Helsinki.
All cases were preliminarily discussed in multidisciplinary
board and indication to surgery was defined in accordance
between surgeons and endocrinologists. The perioperative
management included admission of patients the day before
surgery, subcutaneously antithrombotic prophylaxis 12 hours
before intervention and intravenous specific antibiotic pro-
phylaxis were administered.
Data collection
For all patients, the following data were collected: age,
gender, BMI, comorbidities, American Society of Anesthe-
siologists (ASA) score, perioperative details, characteristics
of adrenal lesion, surgical procedure data and postoperative
outcomes, and length of hospital stay (LOS). Surgical com-
plications were stratified according to Clavien–Dindo clas-
sification.9 Total operative time (OT) was defined as duration
in minutes from skin incision to port-site closure; in case
of additional open resections associated to robotic-assisted
phase, OT was considered from skin incision to the undock-
ing time. For robotic procedures, total time data included
different phases: the docking, the console time, and the un-
docking. Blood loss was considered as the amount of volume
(mL) from drainage.
A comparative analysis between the laparoscopic and ro-
botic technique was conducted. In particular, results in terms
of OT for the two approaches were analyzed in consider-
ation of specific variables: laterality, BMI, and dimension of
adrenal lesion with a cutoff between <6 and ‡6 cm. As we
know, right- and left-side approaches present different ana-
tomical fields and some different technical surgical aspects;
thus, a further subdivision of the cohort into right- and left-
side groups was performed and a comparison between the
two surgical techniques was concluded.
Statistical analysis
All data were collected in an electronic database and
the statistical analyses were performed using the Statistical
Package for the Social Sciences’ (SPSS) software for
Windows (version 25.0; SPSS, Inc., Chicago, IL). For all
comparisons, P < .05 was considered statistically significant.
Continuous variables were reported as median values; the
nonparametric Mann–Whitney U test followed by the Dunn’s
multiple comparison post hoc test were used for compari-
sons of continuous variables resulted not normally distributed
at the Kolmogorov–Smirnov test. Categorical variables were
reported as frequencies and percentages and they were com-
pared by the chi-square test. Pearson’ correlation was used for
continuous variables. Linear regression analysis was used to
examine the association between continuous variables; results
were expressed through b and R2 coefficients. Bivariate lo-
gistic regression was used for categorical variables.10
Results
A total of 172 patients were collected; among these, open
and bilateral procedures were excluded (n = 12), whereas
160 patients received mini-invasive adrenalectomy, includ-
ing 84 cases of LA (laparoscopic adrenalectomy-group
[LA-g]) and 76 cases of robot-assisted procedures (robotic
adrenalectomy-group, RA-g). The two groups resulted ho-
mogeneous for gender, age, BMI, ASA score, and laterality
of presented adrenal lesion; all patients’ demographic and
clinical characteristics are resumed in Table 1. Indications to
laparoscopic or robotic surgery were similar for all patients
and followed international recommendations.2 Diagnosis
was obtained in consideration of clinical symptoms, labora-
tory examinations and radiological imaging. Twenty-eight
cases in LA-g and 20 cases in RA-g were occasional findings
at radiological imaging performed for other reasons.
Imaging studies always included computed tomography
scan; magnetic resonance imaging, positron emission tomog-
raphy, and scintigraphy were performed according to diag-
nostic work-up when required. Mean size of adrenal lesion
was 5.1 cm (range 1.2–16) for LA-g and 4.03 cm (range
0.5–15) for RA-g, P = .019; lesions ‡6 cm were registered in
17.5% and 15.8% of cases among LA-g and RA-g, respec-
tively (P = .010).
Table 2 resumes all perioperative results. In LA-g, 6 cases
of additional resections were performed during the same
laparoscopic surgery (4 cholecystectomies and 2 defenes-
trations of hepatic cysts). In RA-g, two cholecystectomies
were full-robotically performed in combination with adre-
nalectomy, whereas one additional ileal resection requiring
a mini-laparotomy and one left open nephrectomy were, re-
spectively, performed after robot-assisted phase concluded.
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No intraoperative complications were reported for both
groups and the mean amount of intraoperative blood loss was
comparable between LA-g and RA-g (Table 2). No cases of
conversion to open surgery were required. Laparoscopic
approach required more frequently the placing of a drain
(LA-g 97.6% versus RA-g 85.5%, P = .005). Further perio-
perative details are reported in Table 2. Overall mean OT in
LA-g was significantly shorter than robotic one (P = .040). In
all patients the duration of the surgical procedure was directly
correlated to the dimension of the adrenal mass (ß = +0.20;
R2 = 0.042; P = .01).
The mean time to first flatus after surgery was 1.4 days
(range 1–3) for LA-g and 1.1 days (range 1–2) for RA-g
(P = .110). All patients started oral intake on first postoper-
ative day. Abdominal drain was usually removed the day
before patient’s discharge. The overall rate of postoperative
complications at 30 days did not differ between LA-g and
RA-g, being of 21.4% and 10.5%, respectively (P = .087).
Medical complications (i.e., pneumonia, pleural effusion,
and urinary tract infection) were similar between the two
groups (1.9% versus 9.2%, P = .058), whereas an inferior rate
of surgical complications was registered for RA-g if com-
pared with LA-g (1.3% versus 9.5%, P = .024). Postoperative
complications were categorized according to Clavien–Dindo
classification.9 All postsurgical outcomes are reported in
Table 2. One case of left ureteral injury was described and
successfully managed by an ureteral stenting in laparoscopic
group. Discharge criteria consisted in adequate pain con-
trol with oral medication, absence of nausea and or/vomiting,
passage of flatus, nonelemental diet and soft food well-
tolerated, mobilization, and self-support. In our series the
mean LOS was calculated from the day of surgical operation
to the day of discharge; LOS resulted shorter for RA-g than
for LA-g (P = .005). No cases of readmission were reported,
and mortality at 30 days was 0% for both groups. Definitive
pathological findings are summarized in Table 2.
Analysis for laterality
According to our knowledge, this is the first series pre-
senting a comparison between different surgical approaches
(laparoscopic versus robot-assisted) where the laterality of
adrenal gland was applied as further criteria of analysis
(Table 3). Mean laparoscopic OT presented a tendency to be
shorter than robotic one in right side, whereas no differ-
ences between laparoscopy and robot were noted at left side.
Moreover, laparoscopic technique and robotic approach
did not present differences when approaching right-side ad-
renal glands in terms of rates of intra- and postoperative
complications, placement of abdominal drain and need to
transfusions. On the contrary, among left-side group, robotic
technique registered an inferior rate of both medical and
surgical postoperative complications than laparoscopic tech-
nique. Length of hospital stay in both right and left adre-
nalectomy presented a trend in favor of robotic technique.
In consideration of laterality, a further analysis was per-
formed to evaluate the relation between side of the adrenal
lesion, BMI, and diameter of the mass in influencing the
duration of surgical procedure for both laparoscopic and
robotic techniques; all findings are reported in Table 4.
Discussion
In past decades, minimally invasive technique consider-
ably increased its application in abdominal surgery. Parti-
cularly, adrenal surgery assisted to a progressive revolution
in these terms, with the first LA performed in 1992 by Gagner
et al.11 and with the first application of robotic platform in
1999.12,13 According to the last guidelines LA consolidates
its strength of benefits compared with traditional open ap-
proach and it is validated as the gold standard technique with
the lateral transabdominal approach to be preferred than the
posterior one.2 Recently, many authors advocated toward the
safety and satisfactory outcomes of robotic adrenalectomy,14
but today a consensus regarding the true benefit of robotic
surgery over conventional laparoscopy in treating adrenal
pathology remains still under debate.4 Preliminary results are
encouraging in favor of robotic platform, but issues dealing
with procedural operating time and cost effects represent a
Table 1. Demographic Data
and Clinical Characteristics
Total cohort (n = 160)
pLA-g (n = 84) RA-g (n = 76)
Gender
Male 37 (44) 33 (43.4) .936
Female 47 (56) 43 (56.6)
Mean age, years
(range)
57.9 (24–83) 57.2 (17–81) .913




<30 67 (79.8) 67 (88.2) .151
‡30 17 (20.2) 9 (11.8)
ASA
I 14 (16.6) 13 (17.1)
II 50 (59.5) 53 (69.7) .381
III 18 (21.4) 9 (11.8)
IV 2 (2.3) 1 (1.3)
Previous abdominal
surgery
42 (50) 21 (27.6) .004
Mean size,
cm (range)
5.1 (1.2–16) 4.03 (0.5–15) .019
‡6 cm 28 (17.5) 12 (15.8) .010
Laterality
Right side 41 (48.8) 37 (48.7) .886




18 (21.4) 16 (21)
Cushing adenoma 13 (15.4) 12 (15.8)
Conn adenoma 10 (11.9) 19 (25) —
Pheocromocytoma 13 (15.5) 1 (1.3)
Metastasis 14 (16.7) 5 (6.6)
Cystic lesion 2 (2.4) 1 (1.3)
Angiomyolipoma 5 (5.9) 5 (6.6)
Carcinoma 5 (5.9) 3 (3.9)
Hyperplasia 4 (4.8) 1 (1.3)
Oncocytoma — 1 (1.3)
Data presented were n (%), unless specified.
ASA, American Society of Anesthesiologists; BMI, body mass
index (kg/m2); LA-g, laparoscopic adrenalectomy-group; RA-g,
robotic adrenalectomy, group.
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remarkable barrier for the definitive overcome of robotic
system over laparoscopic procedure.4,8
In our study, we report the pluriannual experience in
mini-invasive surgery applied to adrenal pathologies at our
institution, where a specialized endocrine surgeons team is
involved. Our first laparoscopic lateral transabdominal ad-
renalectomy was performed in 2006, and a progressive con-
solidation of its application as the standard treatment was
achieved. With the advent of robotic surgery, the Da Vinci Si
system arrived at our institution in 2005 and since then ro-
botic activity progressively gained success in endocrine,
colorectal, and gastroesophageal activities. Our endocrine
surgical team already reported excellent results in the field of
transaxillary thyroid surgery15; the certainty of being able to
count on mini-invasive surgical skills and clinical compe-
tence allows us today to present one of the largest series
of adrenal gland surgery comparing laparoscopic and robot-
assisted technique. Moreover, in 2011, robotic platform
started to be applied more frequently at our center, until the
proportion with laparoscopy inverted in 2013, registering a
rapid increase of the learning curve.
In 2004, Brunaud et al. presented the first comparison
between laparoscopic and robotic adrenalectomy,16 whereas
the only prospective randomized controlled clinical trial
comparing the two techniques was published by Morino
et al.17; these series were still small, reporting no more than
20 procedures and no clear benefits of robotic approach re-
sulted as major criteria to overcome LA. Nevertheless, at
present the international literature finds accordance in pro-
posing the robotic platform for specific categories of patients,
such as obese (BMI ‡30 kg/m2), where the dissection in narrow
spaces could result easier with robot than laparoscopically.6,16,18
According to our experience, the BMI does not influence the
selection of the surgical procedure; besides, our mean BMI
represents one of the highest value among other robotic series
reported in literature. These data not only show that high BMI
does not represent a contraindication to robotic adrenalectomy,
but that in expert hands obese patients can even benefit from
the robotic dissection. However, other authors consider obesity
an independent risk factor in adrenal surgery.19,20
According to OT, we registered mean values for lapa-
roscopic adrenalectomies and for robotic procedures both
Table 2. Peri- and Postoperative Data
Total cohort (n = 160)
pLA-g (n = 84) RA-g (n = 76)
Perioperative complications — — —
Conversion to open surgery — — —
Mean estimated blood loss, mL (range) 110 (70–250) 90 (50–220) .081
Additional resections 6 (7.1) 2 (2.6) .897
Abdominal drain 82 (97.6) 65 (85.5) .005
Mean operative time, minutes (range) 89.9 (38–230) 100.3 (40–265) .040
Postoperative complications
Medical 10 (1.9) 7 (9.2) .580
Pneumonia (n) 4 2
Pleural effusions (n) 3 4 .024
IVU (n) 3 1
Atrial fibrillation (n) 1 — .619
Surgical 8 (9.5) 1 (1.3)
Hematoma/bleeding (n) 4 —
Abdominal collection (n) 2 1
Ureter injury (n) 1 —
Ileus (n) 1 —
Clavien–Dindo ‡3 1 (1.2) —
Reintervention — — —
Blood transfusions 3 (3.6) — .210
Mean hospital stay, days (range) 4.07 (2–16) 3.2 (2–14) .005
30-Days mortality — — —
Pathological findings
Cushing adenoma 12 (14.3) 9 (11.8)
Conn adenoma 10 (11.9) 12 (15.8)
Metastasis 14 (16.7) 5 (6.5)
Cystic lymphangioma 2 (2.4) 3 (3.9)
Carcinoma 5 (5.9) 1 (1.3)
Myelolipoma 6 (7.1) 5 (6.5)
Nonsecretive adenoma 19 (22.6) 24 (31.5) —
Pheocromocytoma 14 (16.7) 14 (18.4)
Hyperplasia 1 (1.2) 1 (1.3)
Lymphoma 1 (1.2) —
Oncocytoma — 1 (1.3)
Primary pigmented nodular adrenocortical disease — 1 (1.3)
Data presented were n (%), unless specified.
LA-g, laparoscopic adrenalectomy group; RA-g, robotic adrenalectomy group.
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inferior to ones reported by other series currently present in
scientific panorama.4,20 This finding reflects how surgical
experience plays a significant role in determining the
overall duration of surgical operations. As expected, OT
was shorter in LA-g than RA-g when comparing the two
groups. A significantly longer OT is widely attributed to
the use of the robot, accordingly to the robotic setup, the
time needed to advance the robotic cart and connect the
robotic arms to the trocars as well as the undocking phase,
but we strongly believe that additional time may de-
creases as more robotic procedures are performed, with
surgeons acquiring an increasing learning curve and
progressively consolidating their skills. Notably, prior
studies confirmed this concept, as Agcaoglu et al. who
reported a significant improvement in OT after 10 robotic
adrenal procedures,21 and Brunaud et al. observing sim-
ilar results between laparoscopic and robotic adrenalec-
tomy after 20 robot-assisted procedures.18
Interesting is the lower rate of positioning an abdominal drain
in favor of robotic group, reflecting the tendency of reduced risk
of bleeding reported by robotic adrenalectomies4,22 and the
consequent fact that surgeons feel more confident.
Principal complications associated with mini-invasive
adrenalectomy are hemorrhage, injuries of adjacent organs,
wound infection, ileus, atelectasis, and pleural effusion. In
terms of morbidity, no significant difference between RA-g
and LA-g for both peri- and postoperative complications
were reported by a recent metanalysis.4 In our series, we
found a better trend in favor of robotic procedures in terms of
short-term postoperative surgical complications. This result
seems to be very encouraging; Aksoy et al. reported a high
complication rate in the robotic group of 4.8%,5 and inci-
dences reported in literature are also higher, ranging be-
tween 5% and 10%.23,24 Furthermore, we found a significant
shorter hospital stay among the robotic group compared with
laparoscopic one, reflecting data by other authors.5,23,25 The
shorter hospital stay may allow also reducing costs of hos-
pitalization and a higher turnover of patients in surgical
units, thus balancing the principal drawback of robotic plat-
form of higher costs.6,8,26 Brunaud et al. calculated that
Table 4. Comparison of Operative Time (Minutes) Between Laparoscopic Adrenalectomy-Group
and Robotic Adrenalectomy-Group According to Laterality, Body Mass Index, and Lesion Diameter
OT for total cohort (n = 160)
Right side (n = 78) Left side (n = 82)
LA-g (n = 41) RA-g (n = 37) p LA-g (n = 43) RA-g (n = 39) p
BMI <30 88.2 (40–175) 103.3 (50–265) .443 96.4 (65–230) 99.1 (65–150) .300
BMI ‡30 79 (55–116) 108 (90–135) .028 80.3 (53–125) 104.2 (62–135) .230
Lesion <6 cm 82.9 (38–175) 95.4 (45–210) .103 88.5 (40–230) 99 (40–180) .077
Lesion ‡6 cm 92.6 (40–152) 135 (50–265) .110 103.6 (70–205) 105.5 (75–117) .645
Data presented were mean values (minutes).
BMI, body mass index (kg/m2); LA-g, laparoscopic adrenalectomy group; OT, operative time (minutes); RA-g, robotic adrenalectomy
group.
Table 3. Comparison Between Laparoscopic Adrenalectomy-Group
and Robotic Adrenalectomy-Group According to Laterality
Total cohort (n = 160)
Right side (n = 78) Left side (n = 82)
LA-g (n = 41) RA-g (n = 37) p LA-g (n = 43) RA-g (n = 39) p
Gender
Male 19 (46.3) 19 (51.3) .658 18 (41.8) 14 (35.8) .580
Female 22 (53.7) 18 (48.7) 25 (58.2) 25 (64.2)
Mean age, years (range) 56.9 (27–77) 55.5 (19–81) .872 58.9 (83–34) 58.3 (33–77) .896
BMI
<30 32 (78) 32 (86.4) .332 35 (81.4) 35 (89.7) .285
‡30 9 (22) 5 (13.6) 8 (18.6) 4 (10.3)
Previous abdominal surgery 21 (51.2) 11 (29.7) .054 21 (48.8) 10 (25.6) .031
Abdominal drain 40 (97.5) 32 (86.4) .067 42 (97.6) 33 (84.6) .035
Mean operative time, minutes (range) 86.2 (38–175) 103.9 (45–265) .058 93.4 (40–230) 99.6 (40–180) .187
Postoperative complications 5 (12.1) 2 (5.4) .335 13 (30.2) 6 (15.3) .143
Medical 4 (9.7) 2 (5.4) .495 6 (13.9) 5 (12.8) .035
Surgical 1 (2.4) 0 .495 7 (16.2) 0 .036
Blood transfusions 1 (2.4) 0 .377 2 (4.6) 0 .185
Mean hospital stay, days (range) 3.9 (2–16) 3.2 (2–7) .072 4.1 (2–14) 3.7 (2–14) .204
Data presented were n (%), unless specified.
BMI, body mass index (kg/m2); LA-g, laparoscopic adrenalectomy group; RA-g, robotic adrenalectomy group.
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robotic approach was 2.3 times more expensive than lapa-
roscopic one,6 but notably, costs could be curtailed by
increasing the annual workload of robotic surgical proce-
dures in high-volume centers,4,26 leading also to a facilita-
tion of the learning curve. From this cost-saving standpoint,
the widespread adoption of robotic technology may con-
duct to a beneficial effect on robotic purchase, but published
data at present are not sufficient yet and further studies are
necessary.26,27
Nowadays, standard indications of robotic platform to
adrenal surgery have not been validated yet; some authors
have considered the presence of some factors, such as BMI
>30 kg/m2, tumor size >5 cm, and a previous history of
abdominal surgery, as good indicators for robotic prefer-
ence.5,7,18 In our series, no cases of conversion to open sur-
gery was registered notwithstanding adrenal lesions with a
maximum diameter ‡6 cm were 17.5% and 15.8% in LA-g
and RA-g, respectively, and a correlation with the diameter of
lesion was found only with the length of surgical operation.
However, we believe that capsular rupture represents an
important risk when managing adrenal lesions, especially
large lesions and pheocromocytoma; thus, these patients
should be referred to expert centers where robotic approach
may represent a helpful tool to ensure the most atraumatic
and precise manipulation.
To the best of our knowledge, our study describes the first
comparison between laparoscopic and robotic adrenalectomy
according to the laterality of adrenal lesion. Our assumption
arises from the idea that right and left adrenalectomy are
considered as distinct interventions, interfacing with two
different anatomical districts and requiring specific technical
skills. In particular, if right adrenalectomy requires the con-
trol of the inferior vena cava, left adrenalectomy seems to be
more challenging in case of mobilization of the left colic
flexure and the risk of spleen and pancreatic injury.7,16 We
also believe that right adrenalectomy may represent the
starting surgical step for surgeons facing to adrenal surgery
for the first time. From this concept, therefore, the idea of
developing a detailed comparative analysis between the two
techniques for each of the two laterality. No other authors
proposed this type of comparison previously.
In particular, for right adrenalectomy we found a shorter
OT in laparoscopic group, but at left robotic and laparoscopic
techniques resulted in similar procedural duration with no
differences when considering BMI and lesion diameter.
Furthermore, the major advantages of robotic technique were
seen in left adrenalectomy with an inferior rate in positioning
abdominal drainage and lower rates of postoperative mor-
bidity. Robotic system seems to be superior for more com-
plex and difficult cases, especially for large tumors, obese
patients, and left-sided lesions. The correct interpretation of
this stays in the well-known benefits offered by robotic
platform that can strongly prove its effectiveness when
applied to challenging anatomical fields dealing with deep
anatomical structures and requiring maximal accuracy in
dissection.
The strength of this study stays in the homogeneity between
the laparoscopic and robotic groups, the large sample size, and
the subanalysis for the laterality of the adrenal lesions. The
study was conducted in a high-volume center with an estab-
lished mini-invasive surgical experience and where all sur-
gical indications were approved by a multidisciplinary board,
leading to the possibility of a standardization of indications
and technique. However, this study has some limitations. It is
a monocentric study of a nonrandomized series of patients,
based on a retrospective database, the sample is still small and
mainly the first patients may have been selected and addressed
to a specific technique by creating a bias on the conclusions.
Further multicentric prospective randomized trials are nec-
essary to confirm our findings for a larger number of surgeons
in comparable high-volume centers.
Conclusions
Advantages of robotic adrenalectomy over the conven-
tional laparoscopy are still matter of debate and robotic sur-
gery cannot assume a well-defined role in treating adrenal
pathology. According to our experience, the real superiority
of robotic technique can be found when applied to more
challenging cases, including large adrenal masses and obese
patients. Furthermore, left adrenal lesions seem to receive
greater benefits from robotic approach than right sided, with a
minor rate of complications than laparoscopy but with similar
OT. These findings suggest us a routinary application of
robotic left adrenalectomy and only for right-sided selected
cases, but, at present, large randomized controlled trials are
required to extract safe and dependable answers on the po-
tential benefit of robotic approach and to understand if the
technique may be chosen based on the laterality of adrenal
gland; our purpose remains to be validated in future studies.
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